SUBSCRIBE
SUBSCRIBE

Proclara Biosciences

NEWS
Proclara Biosciences ceased operations in 2021.
Alzheimer's Report September 2019
Drug Development
Alzheimer’s Disease Insight Report: Current Therapies, Drug Pipeline and Outlook
50 million people worldwide live with symptomatic Alzheimer’s, which has no cure. In honor of September 21st being World Alzheimer’s Day, we evaluated the current therapies, drugs in the pipeline and disease outlook.
September 18, 2019
 · 
36 min read
 · 
Chelsea Weidman Burke, M.S.
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Genetown
NeuroPhage Transforms Into Proclara, Bags $47 Million and and Launches Phase Ib Alzheimer’s Trial
September 7, 2016
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Genetown
Hunting For Brain Plaques, NeuroPhage Pharmaceuticals, Inc. Makes An Unconventional Move
January 31, 2014
 · 
1 min read
IN THE PRESS
Drug Development
Proclara Biosciences Announces Initiation of NPT189 Clinical Development for Systemic Amyloidoses and Provides Pipeline Update
July 26, 2018
 · 
4 min read
Business
Proclara Biosciences Strengthens Leadership Team with Appointment of David Michelson, M.D., as Chief Medical Officer
January 3, 2018
 · 
3 min read
Drug Development
Proclara Biosciences Presents New Preclinical Data Supporting Development of GAIM-Based Therapies at Society for Neuroscience Annual Meeting
November 14, 2017
 · 
3 min read
Drug Development
Proclara Presents New Preclinical Data Supporting The Development Of NPT189 At Alzheimer’s Association International Conference (AAIC) 2017
July 18, 2017
 · 
2 min read
Drug Development
Proclara Announces Pipeline Progress
July 17, 2017
 · 
4 min read
Business
Exec Who Orchestrated Promedior’s $1.25 Billion Buyout Deal From Bristol-Myers Squibb To Helm Proclara
April 26, 2017
 · 
3 min read
Genetown
Proclara Biosciences Australia, A Subsidiary Of Proclara, Awarded Grant By Biopharmaceuticals Australia To Help Develop New Biotherapy With Blockbuster Potential
March 10, 2017
 · 
2 min read
Genetown
Proclara Awarded Part The Cloud Grant From Alzheimer’s Association To Support Development Of NPT088 For Alzheimer’s Disease
November 18, 2016
 · 
2 min read
Genetown
Proclara Announces Newly Issued U.S. Patents For Its Core Technology Targeting Protein Misfolding Disorders
November 16, 2016
 · 
2 min read
Drug Development
Proclara Announces Initiation Of Phase Ib Clinical Trial Of NPT088 For Alzheimer’s Disease
September 7, 2016
 · 
3 min read
Load More